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Table 1. Hypothesis 1
% denuded bone, analyzed at: Increase* in median pain score,
per 10% increase in denuded
bone, adjusted for age, gender,
BMI, bone edema score (95%CI)
Medial tibial surface 4.46 (1.45, 7.47)
Weightbearing medial femoral surface 5.24 (3.19, 7.28)
Medial tibial + weightbearing medial femoral surface 6.35 (3.10, 9.59)
Medial tibial + weightbearing medial femoral + patellar 6.19 (1.28, 11.10)
*signiﬁcant if 95%CI excludes 0.
Table 2. Hypothesis 2
% denuded bone, analyzed at: Age, gender, BMI, K/L grade,
bone edema score-adjusted OR*
per 10% increase in denuded bone
(95%CI)
Medial tibial surface 1.61 (1.07, 2.42)
Weightbearing medial femoral surface 1.49 (1.13, 1.95)
Medial tibial + weightbearing femoral 1.61 (1.15, 2.26)
Medial tibial + weightbearing medial femoral + patellar 2.44 (1.50, 3.96)
*signiﬁcant if 95%CI excludes 1.
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Purpose: To determine the effect of chondroitin sulfate on structure
modiﬁcation, as measured by change in the rate of decline in minimum
joint space width, in patients with osteoarthritis (OA) of the knee.
Methods: The authors searched MEDLINE from 1996 to 2007 to identify
articles on the effect of chondroitin sulfate on structure modiﬁcation in
patients with knee OA. The reference lists of systematic reviews and
meta-analyses were searched and authors were contacted to identify
additional studies. The primary outcome was the change in minimal joint
space width over one year. One person abstracted data on the change in
minimum joint space width in the placebo-treated and chondroitin sulfate-
treated groups. Whenever possible, we used data from the intention-
to-treat analyses for pooling. For studies of two years in duration, we
assumed that the change was linear over time. Results were summarized
for both the absolute difference between the chondroitin sulfate and
placebo-treated groups as well as the standardized mean difference
(effect size) using the pooled standard deviations. Fixed effects models
were used as the Q and I2 statistics showed no evidence of between-trial
heterogeneity. Sensitivity analyses were also performed.
Meta-analysis of randomized controlled trials of chondroitin sulfate for structure modiﬁcation
Author Chondroitin Sulfate Placebo Difference (mm/year) Effect Size
(Year) No. of
patients
Mean
decline
SD No. of
patients
Mean
decline
SD Mean (95%CI) SMD (95%CI)
Uebelhart
(1998)
14 −0.1 1.24 12 0.4 1.00 −0.50 (−1.36, 0.36) −0.43
(−1.21, 0.36)
Uebelhart
(2004)
39 0.04 0.83 39 0.32 1.12 −0.28 (−0.72, 0.16) −0.28
(−0.73, 0.16)
Michel
(2006)
150 −0.02 0.24 150 0.04 0.28 −0.06 (−0.12, 0.00) −0.23
(−0.46, 0.00)
Reginster
(2007)
309 0.05 0.26 313 0.12 0.27 −0.07 (−0.11, −0.03) −0.26
(−0.42, −0.11)
Summary 512 514 −0.07 (−0.10, −0.03) −0.26
(−0.38, −0.l4)
Results: Six reports of 4 placebo-controlled trials of chondroitin sulfate
in patients with knee OA that reported changes in joint space width were
identiﬁed, including 5 articles (3 that reported on the same trial) and 1
conference abstract. Two trials each were of one and two years in dura-
tion. Overall, the 4 trials enrolled a total of 1026 patients (512 randomized
to chondroitin sulfate and 514 to placebo) (see Table). One pilot study,
including only 26 patients, was published in 1998; the remaining three
trials were published in 2004 or later.
The meta-analysis of all 4 trials found a mean difference of 0.07mm per
year (95% conﬁdence intervals [CI] 0.03, 0.10) in favor of chondroitin
sulfate for retarding the decline in minimal joint space width (P< 0.0001).
This corresponds to an effect size of 0.26 (95%CI: 0.14, 0.38). Sensitivity
analyses excluding the trial published only in abstract form (Reginster
et al [2007]) or excluding the two small trials of only one year in duration
(Uebelhart et al [1998 and 2004]) showed similar signiﬁcant results.
Conclusions: This meta-analysis demonstrates a signiﬁcant small-to-
moderate effect of chondroitin sulfate as a structure modifying drug
for treatment of patients with knee OA as measured by slowing the
rate of decline in minimum joint space width. These results support
recent OARSI treatment recommendations for use of chondroitin sulfate
in patients with knee OA.
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Purpose: There have been numerous of systematic reviews of interven-
tions designed to diminish pain and improve function for patients with
OA, but the comparable effectiveness of such interventions is unclear.
To assess the clinical efﬁcacy of physiotherapeutic (PT) modalities and
interventions available in library of Cochrane reviews, on the pain and
disability in patients with osteoarthritis (OA), applying data from published
systematic Cochrane reviews of RCTs would be a useful method.
Methods: The Cochrane Library was searched for Cochrane reviews
considering patients with OA and different physiotherapeutic interventions
with the aim of reducing pain, and disability. A meta-regression analysis
was applied, for the mixed treatment comparisons, applying the individual
study’s standardized mean difference (SMD) as outcome measure, for
pain and disability, respectively. The statistical random-effects model
was based on a restricted maximum likelihood (REML), mixed-effects
model procedure with intervention as ﬁxed- and trial as random-factor,
respectively. The within study variance was considered known for each
published RCT, based on the explicit SD’s presented in each of the
original Cochrane reviews. A negative SMD favors the intervention on
trial.
Results: The search with “osteoarthritis” in the title resulted in 35 re-
views. Reasons for exclusion was protocols (K = 12), pharmacological
treatments and surgery (K=15), withdrawn (K=1) and 1 study compared
two different kinds of treatment (K = 1). Thus, 6 Systematic Cochrane
Reviews were included in the meta-regression model (patients included,
N=3,016): Lateral wedged insoles (LWI, pain k = 1; disability k = 1),
electromagnetic ﬁeld therapy (EMF, pain k = 2; disability k = 2), exercise
(EXE, pain k = 17; disability k = 18), ultrasonic therapy (UST, pain k = 1;
disability k = 0), thermotherapy (THT, pain k = 1; disability k = 1), and
transcutaneous electrical nerve stimulation (TENS, pain k = 6, disability
k = 1).
Based on the indirect meta-analysis we were able to rank these 6 mutually
independent interventions according to the published efﬁcacy on pain;
data are presented in descending efﬁcacy (SMD) order with the corre-
sponding p-value: EMF (SMD: −1.13, p = 0.003); THT[cold] (SMD: −0.69,
p = 0.21); TENS (SMD: −0.45, p = 0.003); EXE (SMD: −0.43, p = 0.0001);
LWI (SMD: 0.31, p = 0.45); UST (SMD: 0.43, p = 0.34). According to the
published efﬁcacy on disability: THT[cold] (SMD: −1.96, p< 0.0001); EMF
(SMD: −0.81, p = 0.002); TENS (SMD: −0.60, p = 0.08); EXE (SMD: −0.34,
p< 0.0001); LWI (SMD: 0.30, p = 0.24).
Conclusions: Based on this mixed treatment comparison, we provide
quantitative evidence-based efﬁcacy ranking of the PT interventions cur-
rently available as an updated Cochrane review. Based on the reported
pain and disability reduction, it is highly evident (p< 0.0001) that exercise
therapy does beneﬁt the patient; although not necessarily with the largest
magnitude of efﬁcacy. Of the other therapies tested, both EMF and
TENS showed a relevant effect size of moderate statistical signiﬁcance
(p = 0.003 respectively p = 0.03) on pain. In addition, THT and EMF
showed a clinically relevant effect size on disability reduction (p< 0.0001
respectively p = 0.002). The present indirect-comparison provide the clin-
ician a review of the modalities to choose, accordingly LWI, UST might
not be effective in the treatment of osteoarthritis.
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Purpose: Knee osteoarthritis (KOA) is a major cause of pain and
functional impairment among elders and has no medical remedy. The
